| abstract |
The present invention also relates to pharmaceutical preparations useful in therapy and / or prophylaxis in mammals, particularly NF-κB-inducible kinases (also known as NIK or MAP3K14) which are useful in the treatment of cancer, inflammatory diseases, metabolic diseases and autoimmune diseases, Lt; / RTI > The present invention also relates to pharmaceutical compositions comprising such compounds, methods for producing such compounds and compositions, and methods of treating diseases, such as cancer, inflammatory diseases, metabolic diseases such as obesity and diabetes, and autoimmune diseases And to the use of such compounds or pharmaceutical compositions in the treatment or prevention of diseases. |